Systemic Sclerosis
Conditions
Sponsors
Terasawa Tetsuji
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Either inpatient or outpatient 2.Patients who meet the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis 3.Patients with progressive systemic sclerosis with moderate or severe skin thickness
Exclusion criteria
Exclusion criteria: 1.Patients with serious complications associated with systemic sclerosis other than interstitial lung disease 2.Patients with severe chronic lung disease 3.Patients with serious and uncontrollable organ dysfunction not associated with systemic sclerosis 4.Patients with a disease other than systemic sclerosis that necessitates systemic corticosteroid administration within 12 weeks before the start of the observation period 5.Patients with an active infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events, Pharmacokinetics, Efficacy(Exploratory objective) | — |
Contacts
Public ContactMedical Center
Ono Pharmaceutical Co.,LTD
Outcome results
None listed